JP2004315386A5 - - Google Patents

Download PDF

Info

Publication number
JP2004315386A5
JP2004315386A5 JP2003108690A JP2003108690A JP2004315386A5 JP 2004315386 A5 JP2004315386 A5 JP 2004315386A5 JP 2003108690 A JP2003108690 A JP 2003108690A JP 2003108690 A JP2003108690 A JP 2003108690A JP 2004315386 A5 JP2004315386 A5 JP 2004315386A5
Authority
JP
Japan
Prior art keywords
derivative
acid
transglycosylation product
substituents
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003108690A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004315386A (ja
JP4571783B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003108690A priority Critical patent/JP4571783B2/ja
Priority claimed from JP2003108690A external-priority patent/JP4571783B2/ja
Publication of JP2004315386A publication Critical patent/JP2004315386A/ja
Publication of JP2004315386A5 publication Critical patent/JP2004315386A5/ja
Application granted granted Critical
Publication of JP4571783B2 publication Critical patent/JP4571783B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003108690A 2003-04-14 2003-04-14 抗微生物剤 Expired - Fee Related JP4571783B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003108690A JP4571783B2 (ja) 2003-04-14 2003-04-14 抗微生物剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003108690A JP4571783B2 (ja) 2003-04-14 2003-04-14 抗微生物剤

Publications (3)

Publication Number Publication Date
JP2004315386A JP2004315386A (ja) 2004-11-11
JP2004315386A5 true JP2004315386A5 (enExample) 2006-05-11
JP4571783B2 JP4571783B2 (ja) 2010-10-27

Family

ID=33470081

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003108690A Expired - Fee Related JP4571783B2 (ja) 2003-04-14 2003-04-14 抗微生物剤

Country Status (1)

Country Link
JP (1) JP4571783B2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007020795A1 (ja) * 2005-08-12 2007-02-22 Lion Corporation 没食子酸誘導体及びそれを含有する外用剤組成物
CN101209254B (zh) * 2006-12-29 2011-04-20 江苏正大天晴药业股份有限公司 多羟基没食子酰基-β-D-葡萄糖衍生物的用途
GB0819958D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
GB0819959D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
ITTO20110428A1 (it) 2011-05-13 2012-11-14 Rottapharm Spa Esteri dell'acido ialuronico, loro preparazione ed uso in dermatologia
ES2692158T3 (es) 2012-04-23 2018-11-30 University Of Oslo Uso del extracto de tomate como agente antihipertensivo y procedimiento para hacer un extracto de tomate libre de azúcar soluble en agua
CN103044500B (zh) * 2012-12-14 2016-07-06 乐山师范学院 一种有机酸的制备及抗菌应用
GB201223365D0 (en) 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
JP6336424B2 (ja) * 2015-10-09 2018-06-06 日清食品ホールディングス株式会社 抗菌剤および海洋生物の腸炎ビブリオの感染による疾病を抑制する方法
MY199636A (en) 2016-11-02 2023-11-11 Provexis Natural Products Ltd Water soluble tomato extract protects against adverse effects of air pollution
US20190076335A1 (en) * 2017-09-12 2019-03-14 IntraMont Technologies, Inc. Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
CN108904541A (zh) * 2018-07-12 2018-11-30 石河子大学 没食子中抑制牙周疾病致病菌有效部位的生产方法及用途
CN108653338A (zh) * 2018-07-12 2018-10-16 石河子大学 没食子中抑制肠道致病菌的有效部位生产方法及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2997358B2 (ja) * 1992-01-30 2000-01-11 ポーラ化成工業株式会社 皮膚外用剤
JPH08217674A (ja) * 1995-02-16 1996-08-27 Noda Sangyo Kagaku Kenkyusho ヒスチジン脱炭酸酵素阻害剤
JP3571111B2 (ja) * 1995-05-23 2004-09-29 株式会社ポッカコーポレーション 抗微生物剤
US20030203857A1 (en) * 2000-04-11 2003-10-30 Hiromu Ohnogi Remedies
AU2001296253A1 (en) * 2000-09-15 2002-03-26 Cubist Pharmaceuticals, Inc. Antibacterial agents and methods of identification

Similar Documents

Publication Publication Date Title
JP2004315386A5 (enExample)
NL300933I2 (nl) Letermovir
WO2006032342A3 (de) Arzneimittel enthaltend carbonylverbindungen sowie deren verwendung
JP2003503454A5 (enExample)
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
MXPA02012905A (es) Derivados de colquinol como agentes de dano vascular..
WO2005116002A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
JP2003520232A5 (enExample)
IL188606A0 (en) Novel 1,4-benzothiazepine-1,1-dioxide, derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
MX2007013623A (es) Preparacion externa para la piel.
ZA200707353B (en) 4-cyclopropyl-1,2,3-thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same
MXPA05012415A (es) Inhibidores de glutamina fructosa-3-fosfato amidotransferasa (gfat).
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
WO2009064374A3 (en) Oral formulations of bis(thiohydrazide amides)
WO2007010281A3 (en) Use of thiazole derivatives and analogues in disorders caused by free fatty acids
AU2005313582A8 (en) Malonamide derivatives as inhibitors of gamma-secretase for the treatment of Alzheimer's disease
WO2006088814A3 (en) Dosage form and method for sustained release of a substituted pyrazine compound
WO2008061671A3 (en) Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
JP2008513426A5 (enExample)
MX2010002470A (es) Derivados de dimetilciclohexilo como neutralizadores de malos olores.
WO2002009717A1 (en) Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient
WO2005112914A3 (en) Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease